Trina Solar (TSL) Tops Q3 EPS by 16c
Get Alerts TSL Hot Sheet
Join SI Premium – FREE
Trina Solar (NYSE: TSL) reported Q3 EPS of $0.29, $0.16 better than the analyst estimate of $0.13. Revenue for the quarter came in at $741.1 million versus the consensus estimate of $824.87 million.
Total module shipments were 1,361.2 MW, compared with 1,658.3 MW in the second quarter of 2016, and 1,703.2 MW in the third quarter of 2015.
Operations and Business Updates
Manufacturing Capacity
As of September 30, 2016, the Company had the following annualized in-house manufacturing capacities:
- Ingot production capacity of approximately 2.3 GW;
- Wafer capacity of approximately 1.8 GW;
- PV cell capacity of approximately 5.0 GW; and
- PV module capacity of approximately 6.0 GW.
Project Development
In the third quarter of 2016, the Company connected a total of 26.0 MW of PV projects to the grid in China, including 1.4 MW of utility projects and 24.6 MW of DG projects.
As of September 30, 2016, the Company had a total of 1,302.8 MW downstream solar projects in grid-connected operation, including 1,267.6 MW in China, 4.2 MW in the U.S., and 31.0 MW in Europe. The 1,267.6 MW of projects in China consisted of 1,017.1 MW of utility projects and 250. 5 MW of DG projects.
Going Private Transaction and the Extraordinary General Meeting of Shareholders
On August 1, 2016, the Company entered into a definitive agreement and plan of merger, pursuant to which the Company will be acquired by an investor consortium in an all-cash transaction implying an equity value of the Company of approximately $1.1 billion (the "Merger"). The Company has called an extraordinary general meeting of shareholders, to be held at 10:00 a.m. Beijing Time on December 16, 2016, to consider and vote on the Merger.
For earnings history and earnings-related data on Trina Solar (TSL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
- FDA approves Padcev plus Keytruda for muscle-invasive bladder cancer
- BitFuFu reports June 2026 bitcoin output fell 29% month over month
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share